University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Immunotherapy has changed the way physicians treat cancer patients. This approach to therapy targets the immune system to redirect cells toward the tumor. | Immunology ...

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut bacteria interfere with the treatment.

The NHS in Scotland has been slammed for failings as women are left to face life endangering waits for surgery.

Screening for risk factors of ovarian cancer using artificial intelligence, UniSA researchers found that the oral ...

Many gynecological cancer patients face barriers to treatment and support. This Westchester woman helped uncover the gaps and seek solutions.

OnCusp Therapeutics, Inc., a clinical stage biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for cancer patients, today ...

New Zealand women with ovarian cancer finally have funded access to bevacizumab. Pharmac’s announcement yesterday comes ten years after the treatment was funded in Australia, and follows a long fight ...

Researchers determined the clinical classification of more than 90% of potential BRCA2 variants of uncertain significance in ...

Artificial intelligence (AI) models, particularly artificial neural networks and machine learning, outperform traditional methods in predicting post–complete cytoreduction outcomes in patients ...